New Drug Approved for Chronic Graft-Versus-Host Disease

Authors

Institutions

Publication Details

Journal
AJN American Journal of Nursing
Published
2024-11-21
DOI
https://doi.org/10.1097/01.naj.0001095216.07628.14
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New Drug Approved for Chronic Graft-Versus-Host Disease

Diane S. Aschenbrenner
AJN American Journal of Nursing
Hematopoietic Stem Cell Transplantation
article

New Drug Approved for Chronic Graft-Versus-Host Disease

Diane S. Aschenbrenner
article en

Abstract

No abstract available for this paper.
AJN American Journal of NursingVol. 124(12)
Johns Hopkins University (US), The Dialogue (US)
Good health and well-being
Openalex Percentile: Top 66%
Hematopoietic Stem Cell Transplantation
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

New Drug Approved for Chronic Graft-Versus-Host Disease — Diane S. Aschenbrenner · AJN American Journal of Nursing (2024) | TGRS Research Map | TGRS